Live Breaking News & Updates on Galmed Pharmaceuticals Price Performance

Stay updated with breaking news from Galmed pharmaceuticals price performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Galmed Pharmaceuticals (NASDAQ:GLMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research report released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance GLMD stock opened at $0.36 on Friday. Galmed Pharmaceuticals has a 12 month low of $0.26 and a 12 month […] ....

Galmed Pharmaceuticals Price Performance , News Ratings For Galmed Pharmaceuticals Daily , Galmed Pharmaceuticals , Galmed Pharmaceuticals Ltd , Free Report , Get Free Report , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily ,

Galmed Pharmaceuticals (NASDAQ:GLMD) Earns Sell Rating from Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a report released on Sunday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance Shares of GLMD opened at $0.39 on Friday. The stock has a market capitalization of $1.96 million, a […] ....

Galmed Pharmaceuticals Ltd , Galmed Pharmaceuticals Company Profile , Galmed Pharmaceuticals Price Performance , Galmed Pharmaceuticals , News Ratings For Galmed Pharmaceuticals Daily , Get Free Report , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily ,

Galmed Pharmaceuticals (NASDAQ:GLMD) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance NASDAQ:GLMD opened at $0.36 on Tuesday. The company’s 50 day moving average price is $0.40 and its 200-day moving average […] ....

United Kingdom , News Ratings For Galmed Pharmaceuticals Daily , Galmed Pharmaceuticals Ltd , Millennium Management , Raymond James Financial Services Advisors Inc , Walleye Capital , Institutional Trading Of Galmed Pharmaceuticals , Galmed Pharmaceuticals , Cambridge Investment Research Advisors Inc , Galmed Pharmaceuticals Price Performance , Galmed Pharmaceuticals Company Profile , Free Report , Get Free Report , James Financial Services Advisors , Cambridge Investment Research Advisors , Pharmaceuticals Ltd , Galmed Pharmaceuticals Daily , Nasdaq Glmd , Initiated Coverage , Stocknews Com ,